DD123750A5 - - Google Patents

Info

Publication number
DD123750A5
DD123750A5 DD189911A DD18991175A DD123750A5 DD 123750 A5 DD123750 A5 DD 123750A5 DD 189911 A DD189911 A DD 189911A DD 18991175 A DD18991175 A DD 18991175A DD 123750 A5 DD123750 A5 DD 123750A5
Authority
DD
German Democratic Republic
Application number
DD189911A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of DD123750A5 publication Critical patent/DD123750A5/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D457/00Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
    • C07D457/04Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 8
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D457/00Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
    • C07D457/02Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with hydrocarbon or substituted hydrocarbon radicals, attached in position 8

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Anesthesiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DD189911A 1974-12-06 1975-12-05 DD123750A5 (en:Method)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/530,320 US3968111A (en) 1974-12-06 1974-12-06 8,8-Disubstituted-6-methylergolines and related compounds

Publications (1)

Publication Number Publication Date
DD123750A5 true DD123750A5 (en:Method) 1977-01-12

Family

ID=24113222

Family Applications (1)

Application Number Title Priority Date Filing Date
DD189911A DD123750A5 (en:Method) 1974-12-06 1975-12-05

Country Status (28)

Country Link
US (2) US3968111A (en:Method)
JP (1) JPS5813542B2 (en:Method)
AR (1) AR211257A1 (en:Method)
AT (1) AT348142B (en:Method)
AU (1) AU505194B2 (en:Method)
BE (1) BE836309A (en:Method)
BG (1) BG33289A3 (en:Method)
CA (1) CA1064918A (en:Method)
CH (1) CH605937A5 (en:Method)
CS (1) CS199610B2 (en:Method)
DD (1) DD123750A5 (en:Method)
DE (1) DE2554629A1 (en:Method)
DK (1) DK146128C (en:Method)
ES (1) ES443279A1 (en:Method)
FR (1) FR2293204A1 (en:Method)
GB (1) GB1535214A (en:Method)
GR (1) GR59201B (en:Method)
HU (1) HU173985B (en:Method)
IE (1) IE42198B1 (en:Method)
IL (1) IL48572A (en:Method)
NL (1) NL7514177A (en:Method)
PH (1) PH13133A (en:Method)
PL (1) PL102611B1 (en:Method)
RO (1) RO64606A (en:Method)
SE (1) SE421528B (en:Method)
SU (1) SU627757A3 (en:Method)
YU (1) YU304575A (en:Method)
ZA (1) ZA757510B (en:Method)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3968111A (en) * 1974-12-06 1976-07-06 Eli Lilly And Company 8,8-Disubstituted-6-methylergolines and related compounds
USRE30219E (en) * 1974-12-06 1980-02-19 Eli Lilly And Company Method of preparing 8,8-disubstituted-6-methylergolines and related compounds
US4054567A (en) * 1975-08-11 1977-10-18 Eli Lilly And Company 6-Methyl-8β-hydroxymethyl-8-γ-substituted-9-ergolene compounds
US4098790A (en) * 1976-09-15 1978-07-04 Eli Lilly And Company Ergoline chlorination process
US4238486A (en) * 1979-11-23 1980-12-09 Merck & Co., Inc. Indolobenzoxazines
US4382940A (en) * 1979-12-06 1983-05-10 Farmitalia Carlo Erba S.P.A. Ercoline derivatives and therapeutic compositions having CNS affecting activity
DE3001752A1 (de) * 1980-01-16 1981-07-30 Schering Ag Berlin Und Bergkamen, 1000 Berlin Verfahren zur herstellung von 8(alpha)-substituierten 6-methylergolinen
CH644606A5 (de) * 1980-09-23 1984-08-15 Sandoz Ag Verfahren zur isomerisierung von 9,10-dihydrolysergsaeurederivaten.
US4801712A (en) * 1985-06-24 1989-01-31 Eli Lilly And Company 2-Alkyl(or phenyl)thio-6-n-alkylergolines are dopamine D-1 antagonists without D-2 agonist activity
US20030181488A1 (en) 2002-03-07 2003-09-25 Boehringer Ingelheim Pharma Gmbh & Co. Kg Administration form for the oral application of 3-[(2-{[4-(hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl}-1-methyl-1H-benzimidazol-5-carbonyl)-pyridin-2-yl-amino]-propionic acid ethyl ester and the salts thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH344731A (de) * 1956-05-18 1960-02-29 Sandoz Ag Verfahren zur Herstellung von neuen, am Indolstickstoff alkylierten Derivaten der Lysergsäure-Reihe
US2861074A (en) * 1956-10-22 1958-11-18 Lilly Co Eli Substituted hydroxyergolenes
BE755211A (fr) * 1969-08-29 1971-02-01 Spofa Usines Pharma Reunies Procede de preparation des nouvelles amides de l'acide d-6-methyl-8-ergolin/i/yle/acetique et de leurs sels, ainsi que les produits obtenus
AR206772A1 (es) * 1972-07-21 1976-08-23 Lilly Co Eli Procedimiento para preparar una nueva d-2-halo-6-metil-8-ciano(carboxamido)metil ergolina
US3968112A (en) * 1974-08-02 1976-07-06 Eli Lilly And Company Synthesis of penniclavine and elymoclavine
US3968111A (en) * 1974-12-06 1976-07-06 Eli Lilly And Company 8,8-Disubstituted-6-methylergolines and related compounds

Also Published As

Publication number Publication date
JPS5182299A (en:Method) 1976-07-19
CH605937A5 (en:Method) 1978-10-13
DK547475A (da) 1976-06-07
AR211257A1 (es) 1977-11-15
BG33289A3 (en) 1983-01-14
SE421528B (sv) 1982-01-04
FR2293204B1 (en:Method) 1980-06-27
US4075212A (en) 1978-02-21
ATA928075A (de) 1978-06-15
YU304575A (en) 1982-02-28
GB1535214A (en) 1978-12-13
DK146128C (da) 1983-12-05
IE42198B1 (en) 1980-06-18
AU505194B2 (en) 1979-11-15
NL7514177A (nl) 1976-06-09
DK146128B (da) 1983-07-04
IL48572A (en) 1978-12-17
AU8718175A (en) 1977-06-09
US3968111A (en) 1976-07-06
JPS5813542B2 (ja) 1983-03-14
IE42198L (en) 1976-06-06
ES443279A1 (es) 1977-04-16
GR59201B (en) 1977-11-26
FR2293204A1 (fr) 1976-07-02
ZA757510B (en) 1977-07-27
BE836309A (fr) 1976-06-08
SE7513753L (sv) 1976-06-08
RO64606A (fr) 1979-01-15
AT348142B (de) 1979-01-25
IL48572A0 (en) 1976-01-30
HU173985B (hu) 1979-10-28
CS199610B2 (en) 1980-07-31
PL102611B1 (pl) 1979-04-30
DE2554629A1 (de) 1976-06-10
CA1064918A (en) 1979-10-23
SU627757A3 (ru) 1978-10-05
PH13133A (en) 1979-12-12

Similar Documents

Publication Publication Date Title
DK141471C (en:Method)
FR2257632A1 (en:Method)
DK78275A (en:Method)
FR2293204B1 (en:Method)
FI753123A7 (en:Method)
FI750041A7 (en:Method)
AU485556B2 (en:Method)
DE2416465A1 (en:Method)
CS176567B1 (en:Method)
AU7465674A (en:Method)
AU7138274A (en:Method)
CH589327A5 (en:Method)
CH583986A5 (en:Method)
AU481119A (en:Method)
DD115426A2 (en:Method)
AU481340A (en:Method)
AU479719A (en:Method)
AU481375A (en:Method)
AU481639A (en:Method)
AU482149A (en:Method)
CH577643A5 (en:Method)
BE830261A (en:Method)
AU482308A (en:Method)
AU479447A (en:Method)
BG19453A1 (en:Method)